China Licensing

Briding the gap for Western life sciences companies to Asia

JOINT VENTURE WITH YAFO CAPITAL, LTD.

With the idea to have representatives for licensing transactions in Europe and in China, FCF Life Sciences formed a joint venture with Yafo Capital, Ltd. in 2019. Together, we form a unique team to address the needs of our European and Asian clients. Our aim is to facilitate and guarantee a smooth partnering process.

Facts on Yafo Capital, Ltd.

  • Shanghai based advisory firm
  • Established network and access to leading 200+ Pharma and MedTech companies in Asia
  • Team of 20+ professionals with banking and healthcare background
  • ~20 completed transactions within the last five years

ACCESS CHINA FORUM

0
Company presentations
0
Participants
0
Meeting requests
0
Assets presented
FCF co-organizes, together with its partner YAFO Capital, the “ACCESS CHINA Forum”, which will be held online 4x per year.

ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable business development opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.

UPCOMING EVENT

Venture Capital Sentiment Tracker – May 2022

May 2022:

Biotechnology

Medical Technology

Health Technology

Funding Volume (€m)
0
Trend
Funding Volume (€m)
0
Trend
Funding Volume (€m)
0
Trend

Biotechnology

Funding Volume (€m)
0
Trend

Medical Technology

Funding Volume (€m)
0
Trend

Health Technology

Funding Volume (€m)
0
Trend

If you are interested in exploring China licensing opportunities, please contact us: